Literature DB >> 12736272

Thrombospondin-bound integrin-associated protein (CD47) physically and functionally modifies integrin alphaIIbbeta3 by its extracellular domain.

Tetsuro-Takahiro Fujimoto1, Shinya Katsutani, Takeshi Shimomura, Kingo Fujimura.   

Abstract

Integrin-associated protein (IAP/CD47) is a receptor for the C-terminal cell binding domain of thrombospondin (TS). A peptide from the C-terminal cell binding domain, KRFYVVMWKK (4N1K) binds to IAP and stimulates the integrin-dependent cell functions, including platelet aggregation. We investigated the mechanism by which TS-bound IAP modulates the affinity of platelet integrin, alphaIIbbeta3. Platelet aggregation induced by 4N1K was not completely inhibited by energy depletion with sodium azide and 2-deoxy-d-glucose, although ADP or collagen-induced platelet response was completely inhibited. The binding of ligand-mimetic antibody PAC1 to alphaIIbbeta3 was also induced in the energy-depleted platelets. In the transfected Namalwa cells, 4N1K induced activation of the alphaIIbbeta3 with mutated beta3 (Ser-752 to Pro), which is a non-responsive form to inside-out signaling, as well as wild type alphaIIbbeta3. The truncated form of IAP with only the extracellular immunoglobulin-like (Ig) domain was sufficient for the activation of alphaIIbbeta3 in Chinese hamster ovary cells, although the IAP-mediated intracellular signaling was abolished, which was monitored by the absence of down-regulation of mitogen-activated protein kinase phosphorylation. Furthermore, the soluble recombinant Ig domain of IAP induced PAC1 binding to alphaIIbbeta3 on Chinese hamster ovary cells when added with 4N1K. Physical association between the soluble recombinant Ig domain of IAP and purified alphaIIbbeta3 was detected in the presence of 4N1K. These data indicate that the extracellular Ig domain of IAP, when bound to TS, interacts with alphaIIbbeta3 and can change alphaIIbbeta3 in a high affinity state without the requirement of intracellular signaling. This extracellular event would be a novel mechanism of affinity modulation of integrin.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12736272     DOI: 10.1074/jbc.M302194200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

1.  Promotion of neurite and filopodium formation by CD47: roles of integrins, Rac, and Cdc42.

Authors:  Motoaki Miyashita; Hiroshi Ohnishi; Hideki Okazawa; Hiroyasu Tomonaga; Akiko Hayashi; Tetsuro-Takahiro Fujimoto; Nobuhiko Furuya; Takashi Matozaki
Journal:  Mol Biol Cell       Date:  2004-06-23       Impact factor: 4.138

2.  Glanzmann thrombasthenia with acute myeloid leukemia successfully treated by bone marrow transplantation.

Authors:  Tetsuro-Takahiro Fujimoto; Miho Kishimoto; Kazuko Ide; Miyoko Mizushima; Masashi Mita; Nobuo Sezaki; Kensuke Kojima; Katsuji Shinagawa; Kenji Niiya; Mitsune Tanimoto; Kingo Fujimura
Journal:  Int J Hematol       Date:  2005-01       Impact factor: 2.490

Review 3.  CD47 signaling pathways controlling cellular differentiation and responses to stress.

Authors:  David R Soto-Pantoja; Sukhbir Kaur; David D Roberts
Journal:  Crit Rev Biochem Mol Biol       Date:  2015-02-24       Impact factor: 8.250

4.  Surface Glycoproteins of Exosomes Shed by Myeloid-Derived Suppressor Cells Contribute to Function.

Authors:  Sitara Chauhan; Steven Danielson; Virginia Clements; Nathan Edwards; Suzanne Ostrand-Rosenberg; Catherine Fenselau
Journal:  J Proteome Res       Date:  2016-10-20       Impact factor: 4.466

5.  CD98 activation increases surface expression and clusteringof beta1 integrins in MCF-7 cells through FAK/Src- and cytoskeleton-independent mechanisms.

Authors:  Sun Mi Kim; Jang Hee Hahn
Journal:  Exp Mol Med       Date:  2008-06-30       Impact factor: 8.718

6.  Thrombospondin-1 stimulates platelet aggregation by blocking the antithrombotic activity of nitric oxide/cGMP signaling.

Authors:  Jeff S Isenberg; Martin J Romeo; Christine Yu; Christine K Yu; Khauh Nghiem; Jude Monsale; Margaret E Rick; David A Wink; William A Frazier; David D Roberts
Journal:  Blood       Date:  2007-09-21       Impact factor: 22.113

Review 7.  Enhancing cardiovascular dynamics by inhibition of thrombospondin-1/CD47 signaling.

Authors:  Jeff S Isenberg; William A Frazier; Murali C Krishna; David A Wink; David D Roberts
Journal:  Curr Drug Targets       Date:  2008-10       Impact factor: 3.465

Review 8.  Thrombospondin-1: a physiological regulator of nitric oxide signaling.

Authors:  J S Isenberg; W A Frazier; D D Roberts
Journal:  Cell Mol Life Sci       Date:  2008-03       Impact factor: 9.261

9.  Glanzmann thrombasthenia associated with a 21-amino acid deletion (Leu817-Gln837) in glycoprotein IIb due to abnormal splicing in exon 25.

Authors:  Tetsuro-Takahiro Fujimoto; Mihoko Sora; Kazuko Ide; Miyoko Mizushima; Masashi Mita; Shinichiro Nishimura; Kazuhiro Ueda; Kingo Fujimura
Journal:  Int J Hematol       Date:  2004-07       Impact factor: 2.490

10.  Syndecan-1 regulates alphavbeta3 and alphavbeta5 integrin activation during angiogenesis and is blocked by synstatin, a novel peptide inhibitor.

Authors:  DeannaLee M Beauvais; Brian J Ell; Andrea R McWhorter; Alan C Rapraeger
Journal:  J Exp Med       Date:  2009-03-02       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.